02037nam 22005893 450 99634423850331620240426194934.03-8452-3218-8(CKB)4340000000010258(oapen)https://directory.doabooks.org/handle/20.500.12854/55773(MiAaPQ)EBC7430476(Au-PeEL)EBL7430476(EXLCZ)99434000000001025820240418d2024 uy 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierPatentability of Chemical Selection InventionsFirst edition.La Vergne :e-book,2024.©2024.1 online resource (75 pages) illustrationsMunich Intellectual Property Law Center - MIPLC.Originally presented as the author's thesis--Universität München, 2010.3-8329-6524-6 Includes bibliographical references (pages 69-75).The thesis is a response to the recent decisions of the German Federal Court of Justice on the patentability requirements of selection inventions, namely, the Olanzapine and Escitalopram decisions.DrugsPatentsPatent laws and legislationCasesConflict of lawsPatentsCasesDrug developmentOlanzapineCitalopramMarkenrechtUrheberrecht / Gewerblicher Rechtsschutz und MedienrechtGewerblicher RechtsschutzDrugsPatent laws and legislationConflict of lawsPatentsDrug development.Olanzapine.Citalopram.Ahn Hyewon899875MiAaPQMiAaPQMiAaPQBOOK996344238503316Patentability of Chemical Selection Inventions4155955UNISA